NuVasive CEO Alexis V. Lukianov sold 5,313 shares of the stock in a recent transaction, according to an Inter Cooler report.
Here are five things to know about the transaction and the company's stock:
• The shares were sold at an average price of $44.82, for a total value of $238,128.
• Mr. Lukianov now directly owns 328,367 shares of the company's stock, valued at approximately $14.7 million.
• NuVasive currently has an average rating of "buy" and a consensus price target of $52.27.
• The company has a one-year low of $31.35 and a one-year high of $51.23.
• NuVasive's market cap is $2.136 billion.
More articles on devices:
FDA approves Tornier's shoulder system, aims to improve shoulder arthroplasty — 4 things to know
Piper Jaffray assumes Integra LifeSciences coverage — 5 things to know
Zimmer sells $7.65B of senior notes for Biomet merger — 7 key notes